Last quarter (Q3 2025), Altimmune's total revenue was $5.00K, a decrease of 0.00% from the same quarter last year. In Q3, Altimmune's net income was $-19.01M. See Altimmune’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 20.00K	$ 426.00K	$ -68.00K	$ 4.41M	$ 8.19M
Gross Profit	$ 20.00K	$ 426.00K	$ -68.00K	$ 4.41M	$ -25.32M
Operating Expenses	$ 103.19M	$ 96.36M	$ 87.67M	$ 101.32M	$ 29.47M
Depreciation and Amortization	$ 238.00K	$ 477.00K	$ 493.00K	$ 551.00K	$ 428.88K
EBITDA	$ -94.81M	$ -87.94M	$ -84.41M	$ -96.53M	$ -38.10M
Operating Income	$ -103.17M	$ -95.93M	$ -87.74M	$ -96.91M	$ -54.80M
Other Income/Expenses	$ 8.11M	$ 7.48M	$ 2.83M	$ -176.00K	$ 11.17M
Pretax Income	$ -95.06M	$ -88.45M	$ -84.91M	$ -97.09M	$ -43.63M
Net Income	$ -95.06M	$ -88.45M	$ -84.71M	$ -97.09M	$ -49.04M
Per Share Metrics
Basic EPS	$ -1.34	$ -1.66	$ -1.81	$ -2.35	$ -1.91
Diluted EPS	$ -1.34	$ -1.66	$ -1.81	$ -2.35	$ -1.91
Weighted Average Shares Outstanding	71.00M	53.25M	46.93M	41.28M	25.64M
Weighted Average Shares Outstanding (Diluted)	71.00M	53.25M	46.93M	41.28M	25.64M

Currency in USD

Altimmune Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing